A detailed history of George Soros (Soros Fund Management LLC) transactions in Evolus, Inc. stock. As of the latest transaction made, Soros Fund Management LLC holds 850,000 shares of EOLS stock, worth $14.3 Million. This represents 0.23% of its overall portfolio holdings.

Number of Shares
850,000
Previous 840,100 1.18%
Holding current value
$14.3 Million
Previous $11.8 Million 21.59%
% of portfolio
0.23%
Previous 0.29%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$10.45 - $13.76 $103,455 - $136,224
9,900 Added 1.18%
850,000 $9.22 Million
Q1 2024

May 15, 2024

BUY
$9.99 - $14.91 $2.9 Million - $4.33 Million
290,100 Added 52.75%
840,100 $11.8 Million
Q4 2023

Feb 14, 2024

BUY
$7.6 - $10.53 $4.18 Million - $5.79 Million
550,000 New
550,000 $5.79 Million

Others Institutions Holding EOLS

About Evolus, Inc.


  • Ticker EOLS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 56,094,800
  • Market Cap $943M
  • Description
  • Evolus, Inc., a performance beauty company, provides medical aesthetic products for physicians and their patients in the United States. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. The company was incorp...
More about EOLS
Track George Soros's Portfolio

Track George Soros Portfolio

Follow George Soros (Soros Fund Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Soros Fund Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Soros Fund Management LLC and George Soros with notifications on news.